Diagnosis

Direct-Acting Antivirals Achieve High Cure Rates

Hepatitis C virus (HCV) is a significant public health issue, with an increasing seroprevalence of anti-HCV antibodies from 2.3% to 2.8% between 1990 and 2005….

Gabriella McCarty,

MSN, NP-C
Nurse Practitioner, North Shore Gastroenterology

Patient Management Guidelines

Articles

US Lagging in HCV Elimination: White House Proposes Plan

Hepatitis C virus (HCV) elimination is a critical global health objective, yet the US is falling short of the World...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Hepatitis C Causes Severe Kidney Injury, Highlighting Need for Effective Treatment and Prevention

Hepatitis C (HCV) can cause kidney injury through immune complexes, cryoglobulins, and direct viral effects, leading to acute kidney injury...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Coinfection with HIV, HBV, and HCV: Challenges and Future Therapies

Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are blood-borne viruses with shared transmission routes,...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Study Reveals Long-Term Effects of DAA Treatment on Thrombocytopenia and Leukocytopenia in HCV-Cirrhosis Patients

Thrombocytopenia due to hypersplenism is a common complication of hepatitis C virus (HCV)-associated cirrhosis. While HCV eradication has shown improvement...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

NHANES Data Show 2 Million US HCV Cases: Calls for Improved Testing and Treatment

A study using 2013-2016 National Health and Nutrition Examination Survey (NHANES) data to update hepatitis C virus (HCV) infection prevalence...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

Report Highlights Shift to Noninvasive Tests for Liver Fibrosis Assessment in Patients With HCV Amid DAA Treatments

In a report, researchers discussed the evolving role of noninvasive tests (NITs) in assessing liver fibrosis in chronic hepatitis C...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

Company
Contact

Partner with Us
Ambassador Program

Diagnosis

Direct-Acting Antivirals Achieve High Cure Rates

Gabriella McCarty,

Patient Management Guidelines

Articles

US Lagging in HCV Elimination: White House Proposes Plan

Hepatitis C Causes Severe Kidney Injury, Highlighting Need for Effective Treatment and Prevention

Coinfection with HIV, HBV, and HCV: Challenges and Future Therapies

Study Reveals Long-Term Effects of DAA Treatment on Thrombocytopenia and Leukocytopenia in HCV-Cirrhosis Patients

NHANES Data Show 2 Million US HCV Cases: Calls for Improved Testing and Treatment

Report Highlights Shift to Noninvasive Tests for Liver Fibrosis Assessment in Patients With HCV Amid DAA Treatments

© 2024 Point of Care Network, LLC. All Rights Reserved.

© 2024 Point of Care Network, LLC. All Rights Reserved.

Share